GU oncology update from ESMO 2024

2 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Dr Ray Manneh Kopp shares his views on the latest data on GU cancers presented at the ESMO 2024 congress.

Watch as he reveals what he considers to be the key clinical takeaways from the following GU cancer trials:

NIAGARA

EORTC-GUCG 1333/PEACE-3

TiNivio-2



COR2ED brings together a selection of top experts across many tumour types, presenting their thoughts and insights on the most recent data to emerge from ESMO. Visit our other ESMO 2024 conference update videos here: https://cor2ed.com/n-connect/programmes/esmo-2024-lung-hcc-gi-breast-gu/



Subscribe to the COR2ED channel above to be the first to see our new Independent Medical Education programmes as they are released.



Follow GU CONNECT on social media:

X – https://twitter.com/guconnectinfo

LinkedIn – https://www.linkedin.com/company/gu-connect/



Published September 2024

The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by COR2ED.


This video was developed by https://cor2ed.com/
Category
Oncology
Be the first to comment

Up Next